Zobrazeno 1 - 10
of 86
pro vyhledávání: '"H. H. Schrenk"'
Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines
Autor:
H.-H. Schrenk, P. Kremer, Hannsjörg Sinn, U. Bauder-Wüst, N. Eschen, G. Hartung, I. Kiprianova, E. Frei
Publikováno v:
International journal of clinical pharmacology and therapeutics. 40(12)
Autor:
M, Weigand, G, Hartung, J, Roboz, S, Sieger, M, Wolf, H, Sinn, H H, Schrenk, M, Wiessler, E, Frei
Publikováno v:
Anti-cancer drug design. 16(4-5)
Limitations of low mol. wt anticancer drugs are short tumor exposure times and toxicity to normal tissue. Methotrexate (MTX) covalently linked to human serum albumin (HSA) as a macromolecular carrier caused tumor regressions concomitant with a favora
Autor:
G, Hartung, G, Stehle, H, Sinn, A, Wunder, H H, Schrenk, S, Heeger, M, Kränzle, L, Edler, E, Frei, H H, Fiebig, D L, Heene, W, Maier-Borst, W, Queisser
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(4)
Methotrexate-albumin conjugate (MTX-HSA) is a novel human albumin-based prodrug conjugate of methotrexate (MTX). A low MTX loading rate provided optimal tumor targeting and therapeutic efficacy during preclinical testing. The objectives of this first
Publikováno v:
International journal of cancer. 76(6)
We have recently reported that albumin accumulates in solid tumors and serves there as a source of nitrogen and energy. Methotrexate-albumin conjugates [MTX(I)-RSA] derivatized at a molar ratio of 1:1 differ favorably from original MTX in terms of pl
Publikováno v:
Anti-cancer drugs. 8(7)
Albumin dominates the plasma proteins in man. Following our observation that albumin turnover in rodent tumors is markedly increased, we will present evidence that albumin can be employed as an efficient carrier for targeting cytostatic agents like m
Autor:
F. Rappaport, I. Reifer, H. Weinmann, L. Malaprade, S. M. Strepkov, W. P. Yant, S. J. Pearce, H. H. Schrenk
Publikováno v:
Zeitschrift für Analytische Chemie. 115:357-362
Autor:
H. H. Schrenk
Publikováno v:
Industrial & Engineering Chemistry. 46:99-102
Autor:
H. H. Schrenk
Publikováno v:
Industrial & Engineering Chemistry. 48:61A-66A
Autor:
H. H. Schrenk
Publikováno v:
Industrial & Engineering Chemistry. 43:111A-116A
Autor:
H. H. Schrenk
Publikováno v:
Industrial & Engineering Chemistry. 46:111A-114A